Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chubb
Dow
US Department of Justice
Julphar
Fuji
Daiichi Sankyo
Novartis
UBS
Express Scripts

Generated: January 21, 2018

DrugPatentWatch Database Preview

MEDICIS Company Profile

« Back to Dashboard

Summary for MEDICIS
International Patents:178
US Patents:26
Tradenames:19
Ingredients:17
NDAs:20

Drugs and US Patents for MEDICIS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis ZYCLARA imiquimod CREAM;TOPICAL 022483-001 Mar 25, 2010 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medicis THEOLAIR theophylline TABLET;ORAL 086399-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medicis LOPROX ciclopirox SHAMPOO;TOPICAL 021159-001 Feb 28, 2003 AT RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medicis SYNACORT hydrocortisone CREAM;TOPICAL 087458-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medicis ZYCLARA imiquimod CREAM;TOPICAL 022483-001 Mar 25, 2010 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medicis SOLODYN minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 050808-002 May 8, 2006 DISCN Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Medicis SOLODYN minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 050808-002 May 8, 2006 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medicis SOLODYN minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 050808-005 Jul 23, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Medicis AMMONUL sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 020645-001 Feb 17, 2005 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for MEDICIS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medicis ZIANA clindamycin phosphate; tretinoin GEL;TOPICAL 050802-001 Nov 7, 2006 ➤ Subscribe ➤ Subscribe
Medicis MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 020014-001 Nov 30, 1992 ➤ Subscribe ➤ Subscribe
Medicis METROGEL-VAGINAL metronidazole GEL;VAGINAL 020208-001 Aug 17, 1992 ➤ Subscribe ➤ Subscribe
Medicis ALDARA imiquimod CREAM;TOPICAL 020723-001 Feb 27, 1997 ➤ Subscribe ➤ Subscribe
Medicis METROGEL-VAGINAL metronidazole GEL;VAGINAL 020208-001 Aug 17, 1992 ➤ Subscribe ➤ Subscribe
Medicis ZIANA clindamycin phosphate; tretinoin GEL;TOPICAL 050802-001 Nov 7, 2006 ➤ Subscribe ➤ Subscribe
Medicis ALDARA imiquimod CREAM;TOPICAL 020723-001 Feb 27, 1997 ➤ Subscribe ➤ Subscribe
Medicis LOPROX ciclopirox SHAMPOO;TOPICAL 021159-001 Feb 28, 2003 ➤ Subscribe ➤ Subscribe
Medicis METROGEL-VAGINAL metronidazole GEL;VAGINAL 020208-001 Aug 17, 1992 ➤ Subscribe ➤ Subscribe
Medicis LOPROX ciclopirox SHAMPOO;TOPICAL 021159-001 Feb 28, 2003 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for MEDICIS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Cream 2.5% ➤ Subscribe 6/17/2014
➤ Subscribe Cream 3.75% ➤ Subscribe 8/8/2012
➤ Subscribe Extended-release Tablet 105 rng ➤ Subscribe 12/28/2010
➤ Subscribe Gel 1.2%/0.025% ➤ Subscribe 12/17/2010
➤ Subscribe Extended-release Tablet 55 mg and 80 mg ➤ Subscribe 12/2/2010
➤ Subscribe Extended-release Tablets 65 mg and 115 mg ➤ Subscribe 11/19/2009
➤ Subscribe Cream 0.10% ➤ Subscribe 1/31/2008
➤ Subscribe Cream 5% ➤ Subscribe 10/17/2006
➤ Subscribe Gel 0.77% ➤ Subscribe 5/10/2006
➤ Subscribe Vaginal Gel 0.75% ➤ Subscribe 9/2/2004

Non-Orange Book US Patents for MEDICIS

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,517,847 Topical gel delivery system ➤ Subscribe
9,370,509 2.times.2.times.2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod ➤ Subscribe
9,085,554 Method of evaluating pharmaceutical preparation containing luliconazole and index substance ➤ Subscribe
9,271,973 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy ➤ Subscribe
7,217,422 Compositions and methods for enhancing corticosteroid delivery ➤ Subscribe
7,771,733 Compositions and methods for enhancing corticosteroid delivery ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for MEDICIS Drugs

Supplementary Protection Certificates for MEDICIS Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015 00014 Denmark ➤ Subscribe PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150115
C0055 France ➤ Subscribe PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
90062-5 Sweden ➤ Subscribe PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
90049-3 Sweden ➤ Subscribe PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322
C/GB98/040 United Kingdom ➤ Subscribe PRODUCT NAME: RABEPRAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE SODIUM SALT; REGISTERED: UK 10555/0010 19980508; UK 10555/0008 19980508
C/GB98/025 United Kingdom ➤ Subscribe PRODUCT NAME: MONTELUKAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY MONTELUKAST SODIUM; REGISTERED: FI 12766 19970825; FI 12767 19970825; UK 00025/0357 19980115; UK 00025/0358 19980115
C0021 France ➤ Subscribe PRODUCT NAME: PEGAPTANIB SODIUM; REGISTRATION NO/DATE: EU/1/05/325/001 20060131
C/GB10/012 United Kingdom ➤ Subscribe PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
90020-1 Sweden ➤ Subscribe PRODUCT NAME: SACUBITRIL AND VALSARTAN, AS SACUBITRIL VALSARTAN SODIUM SALT COMPLEX, I.E. TRISODIUM 3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3- ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3-METHYL-2- (PENTANOYL2-(TETRAZOL-5-YLATE)BIPHENYL-4- YLMETHYLAMINO)BUTYRATE HEMIPENTAHYDRATE; REG. NO/DATE: EU/1/15/1058 20151123
C0013 France ➤ Subscribe PRODUCT NAME: DASABUVIR OU UN SEL DE CELUI-CI, NOTAMMENT LE SEL DE SODIUM; REGISTRATION NO/DATE: EU/1/14/983 20150119
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Citi
McKesson
Covington
Chubb
Colorcon
Farmers Insurance
Merck
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot